Evolution of peritoneal dialysis in France since 2018 and during the «COVID years. RDPLF data report
DOI:
https://doi.org/10.25796/bdd.v5i3.67903Keywords:
Peritoneal dialysis, transfers, COVID-19, prevalence, incidence, home dialysis, transplantationAbstract
Almost all (99%) of the patients treated by peritoneal dialysis in France are registered in the RDPLF database. Apart from any statistical analysis aimed at interpreting the figures, this work is a report of the raw data observed in the population of Stage V renal failure patients treated by peritoneal dialysis since the beginning of the Covid epidemic and in the two years preceding it. Since the beginning of the epidemic, these data seem to show a decrease in the incidence of peritoneal dialysis treatment and an increase in transfers to center-based hemodialysis. In addition, there has been a decrease in the number of registrations on the transplant waiting list and a decrease in the number of transplants. While the temporary decrease in transplantation activity may be explained by the disorganization caused by the epidemic in the hospitals, a decrease in the number of indications for home dialysis probably merits further reflection on its causes, especially since this result is in contrast with trends in other countries. This report is intended to encourage more precise studies on the value of home dialysis during the epidemic.
INTRODUCTION
The occurrence of the SARS-Cov2 epidemic has had dramatic consequences on the morbidity and mortality of patients with stage-V chronic kidney disease or transplanted patients. In France, the evolution of the rate of contamination and lethality is communicated weekly by the Agence de Biomédecine and the REIN registry[1]. While many teams around the world have recommended prioritizing home dialysis and particularly peritoneal dialysis (PD)[2];[3];[4], we thought it was important to investigate the situation in France.
We report the evolution of PD in France since 2018. This is raw data extracted from the RDPLF database, specifically from its main module that represents 99% of patients treated with PD in France. We present this information in the form of tables and graphs, without interpretation, with our aim being to provide the reader with immediately accessible general information that can be used as a support for oral presentations and as a basis for reflection for future work. All tables and figures may be freely used provided that their origin is cited (reference of this article or at least its DOI).
I - PROFILE OF PATIENTS TREATED WITH PERITONEAL DIALYSIS IN MAINLAND FRANCE IN 2021
Prevalent patients in the year(Table IandFigure 1)
Sexe ratio : women : 36,4 % Men : 63,6 %
| All patients | CAPD | APD | |
|---|---|---|---|
| Numbers | 4110 | 2568 | 1542 |
| Age | 66,2±16,2 | 70,6±14,2 | 58,9±16,8 |
Figure 1.Age distribution of PD patients treated in 2021
Diabetes status
44.8% of patients treated with peritoneal dialysis in metropolitan France in 2021 had diabetes. The distribution of patients according to diabetic status and treatment of their diabetes is summarized inTable II.
Among diabetic patients on insulin, 98.7% were on subcutaneous insulin and 1.34% on intraperitoneal insulin.
| Diabetic status | Percentages |
|---|---|
| Non-diabetics | 65,28% |
| Diabetics treated with diet | 4,21% |
| Orally treated diabetics | 6,89% |
| Diabetics on subcutaneous insulin | 23,31% |
| Diabetics on intraperitoneal insulin | 0,32% |
Autonomy and PD type (CAPD vs APD)
In 2021, 43.7% of patients required assistance to perform their peritoneal dialysis; this assistance is mostly provided by private nurses at home, paid by national health insurance (Table III).
| Autonomy | Numbers | Percentages |
|---|---|---|
| Autonomous | 2314 | 0.56302 |
| Nurse assisted | 1560 | 0.37956 |
| Family assisted | 213 | 0.05182 |
| Assisted (unspecified) | 21 | 0.00511 |
| Missing data | 2 | 0.00049 |
| CAPD | APD | |
|---|---|---|
| Number/% | 1748 (61%) | 1095 (49%) |
| Age | 70.7±13,5 | 60.5±15,1 |
| Sex ratio (F/M) | 38.4%/61.6% | 33.6%/66.7% |
| Diabetics | 40.6% | 24.7% |
| Autonomous | 45.1% | 81.9% |
| Nurse assisted | 50.3% | 13.35% |
| Family assisted | 4.6% | 4.75% |
CAPD patients are older than those on APD, more often diabetic and 50% require nurse assistance, contrary to APD where the majority (nearly 82%) are autonomous (Table IV).
Partition of PD techniques at 31 December 2021
On December 31, 2021, 2724 patients were treated by PD in metropolitan France, 1714 (63%) in CAPD and 1010 (37%) in APD.
In CAPD, the age was 70.6 years±13.6, the sex ratio was 38% female and 61.7% male. In APD the age was 60 years±16.2 and the sex ratio was 33.6% women and 66.4% men.
Figure 2shows the distribution of the PD technique used according to age.
Figure 2.Age distribution of patients treated with CAPD or APD, on December 2021. Percentages in a technique, CAPD or APD, are calculated in relation to the total number in the technique.
Peritoneal infections in 2021
The latest ISPD guidelines recommend that peritonitis recidives should not be counted in the calculation of the peritonitis rate; nevertheless, clinical recurrences are indeed additional stresses for patients and their peritoneal membrane, so we report the results with and without counting recurrences. All calculations were computed using the method recommended by ISPD[5].
- Rate of peritoneal infection (including recidives): 1 episode every 37.8 months or 0.32 episodes per year
- Rate of peritoneal infection (excluding recidives): 1 episode every 40 months or 0.30 episodes per year
TheTable Vsummarizes the distribution of organisms cultured in 2021. Multiple germ peritonitis is not detailed but is the subject of an accepted work in the journal Nephrology Dialysis and Transplantation (in press)[6].
The percentage of aseptic peritonitis was 15.1%, in line with international recommendations. However, it should be remembered that the rate of culture-negative peritonitis may vary considerably between centers, as we have previously shown[7].
| Germs | Numbers | Percentages |
|---|---|---|
| Gram Plus cocci | 387 | 44,7% |
| Gram negative Bacilli | 231 | 26,7% |
| Gram plus bacilli | 39 | 4,5% |
| Negative cultures | 131 | 15,1% |
| Multiple germs | 62 | 7,2% |
| Yeasts | 10 | 1,2% |
| Gram less cocci | 5 | 0,6% |
| Various | 1 | 0,1% |
Waiting times for 2021 transplanted patients (Table VI)
| Duration of treatment before transplant | Numbers | Percentages |
|---|---|---|
| 0-1 years | 27 | 13,2% |
| 1-2 years | 73 | 35,6% |
| 2-3 years | 47 | 22,9% |
| 3-4 years | 24 | 11,7% |
| 4-5 years | 14 | 6,8% |
| 5 years and more | 20 | 9,8% |
References
- Situation de l’épidémie de COVID-19 chez les patients dialysés et greffés rénaux en France au 29 août 2022. BULLETIN N°106[Internet].
Available at https://www.agence-biomedecine.fr/IMG/pdf/bulletin_no106.pdf
- Cozzolino M, Conte F, Zappulo F, Ciceri P, Galassi A, Capelli I, Magnoni G, La Manna G. COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis? Clin Kidney J. 2021 Feb 2;14(Suppl 1):i6-i13. doi: 10.1093/ckj/sfab023. DOI: https://doi.org/10.1093/ckj/sfab023
- Rostoker G, Issad B, Fessi H, Massy ZA. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective. J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. DOI: https://doi.org/10.1007/s40620-021-01061-7
- Canney M, Er L, Antonsen J, Copland M, Singh RS, Levin A. Maintaining the Uptake of Peritoneal Dialysis During the COVID-19 Pandemic: A Research Letter. Can J Kidney Health Dis. 2021 Feb 15;8:2054358120986265. doi: 10.1177/2054358120986265. DOI: https://doi.org/10.1177/2054358120986265
- Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022 Mar;42(2):110-153. DOI: https://doi.org/10.1177/08968608221080586
- Valentine Forté, Sophie Novelli, Mohamad Zaidan, Renaud Snanoudj, Christian Verger, Séverine Beaudreuil. Microbiology and outcomes of polymicrobial peritonitis associated with peritoneal dialysis: a register-based cohort study from the French Language Peritoneal Dialysis Registry (RDPLF). NDT (accepted september 2022)
- Verger C, Veniez G, Dratwa M. Variability of aseptic peritonitis rates in the RDPLF. Bull Dial Domic [Internet]. 2018 Jun. 13 [cited 2022 Sep. 5];1(1):9-13. Available from: https://doi.org/10.25796/bdd.v1i1.30 DOI: https://doi.org/10.25796/bdd.v1i1.30
- Lucas Pierre-michel J, Collart F, Baudoux T, Bonvoisin C, De Smet J-M, Devresse A, Mbaba Mena J, Radermacher L, des Grottes J-M. Has COVID-19 reduced the management of end-stage kidney disease in 2020? . Bull Dial Domic [Internet]. 2021 Apr. 7 [cited 2022 Sep. 5];4(1):53-4.
Available from: https://doi.org/10.25796/bdd.v4i1.61453 DOI: https://doi.org/10.25796/bdd.v4i1.61453
- Rivara MB, Mehrotra R. The changing landscape of home dialysis in the United States. Curr Opin Nephrol Hypertens. 2014 Nov;23(6):586-91. doi: 10.1097/MNH.0000000000000066. DOI: https://doi.org/10.1097/MNH.0000000000000066
Downloads
Submitted
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Christian Verger, Emmanuel Fabre

This work is licensed under a Creative Commons Attribution 4.0 International License.






